Topics in Neurology
Staying Up to Date with Evolving Changes in Alzheimer’s Management
Expanding DMD Treatment Options for Patients with MS
Restless Legs Syndrome: Selecting Therapy and Managing Augmentation (RLS)
Balancing the Management of Motor and Non-motor Symptoms in Parkinson's Disease
Rockpointe.com The confluence of medical science and clinical need

A series of Live Grand Rounds Programs and an on-demand CME-certified Webcourse

The Potomac Center for Medical Education welcomes you to "Oncology Exchange: A resource for incology professionals. Portal features CME-certified activitiesfor oncologists and other healthcare professionals who treat patients with varios types of cancer. Materials for hospitals hosting live Oncology Exchange programs.

The diagnosis and management of multiple sclerosis (MS) is evolving with the ongoing emergence of disease-modifying drugs (DMDs), diagnostic criteria, and MRI measures and biomarkers capable of improving disease surveillance. Combined with a continued push for earlier diagnosis and initiation of DMD therapy, MS diagnosis and management is becoming increasingly complex.

These programs review the latest research and clinical management information on DMD therapies, diagnostic MRI measures, and biomarkers, in order to provide neurologists and other MS specialists with the knowledge and skills needed to improve the management of patients with MS. [Click on the red title blocks (above) for details on each program.]

These activities are jointly provided by the Potomac Center for Medical Education and Rockpointe.

Multiple Sclerosis
Steering Committee

James Bowen, MD
Suhayl
Dhib-Jalbut, MD
Aaron E. Miller, MD

Expanding DMD Treatment Options for Patients with MS is supported through educational grants from Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

Addressing Challenging Cases in the Management of DMD Therapy for MS is supported through an independent educational grant from Teva Pharmaceuticals.

The cardinal motor symptoms of Parkinson's disease (PD), upon which the clinical diagnosis depends, include bradykinesia, resting tremor, rigidity, and postural instability. These symptoms are primarily the result of the degeneration of the dopamine-producing cells in the substantia nigra.

However, a wide range of both motor and non-motor symptoms, as well as extensive research, demonstrate the involvement of other neuro-transmitters. This has led to the use of a wide variety of medications to treat these symptoms, making the comprehensive management of PD increasingly complex. This program will provide clinicians with a better understanding of the mechanisms leading to the development of PD, as well as an improved ability to manage both the motor and non-motor symptoms. [See details]

Parkinson's Disease
Steering Committee

Yvette M. Bordelon, MD, PhD
Cheryl H. Waters, MD, FRCPC

This activity is jointly provided by the Potomac Center for Medical Education and Rockpointe.
This activity is supported through an Independent educational grant from Teva Pharmaceuticals.

There are more than 5 million Americans living with Alzheimer’s disease (AD). Based on the aging US population, that number is expected to increase to more than 13 million by 2050. To put the scope of the disease into proper perspective, it is important to note that the mortality rate of AD has increased at more than 300% over the last 20 years, and it is now the fourth-leading cause of mortality in the US. Advances in the science underlying AD are also emerging at a rapid rate, while a large number of potential agents are undergoing clinical trials.

The overwhelming amount of material being published on AD makes it essential that practicing neurologists receive educational updates on advances in AD science and management. Staying Up to Date with Evolving Changes in Alzheimer’s Management is designed to inform clinicians of these advances and provide them with the tools needed to rapidly incorporate this knowledge and appropriate treatment options into clinical practice. [See details]

Alzheimer's Disease
Steering Committee

Marwan Sabbagh, MD, FAAN
R. Scott Turner, MD, PhD

This activity is jointly provided by the Potomac Center for Medical Education and Rockpointe.
This activity is supported through educational grants from Biogen, GE Healthcare, and Lilly.

Appropriate treatment of epilepsy requires proper identification of the type of seizure involved; however, this work-up is not always completed in a timely fashion and many patients receive treatment prior to an accurate diagnosis. Even with proper identification of seizure type, treatment can be a challenge. Up to 30% of patients will remain refractory to medication.

In addition, with a large selection of anticonvulsant treatment options and a growing amount of clinical-trial data, selecting the optimal treatment regimen for each individual patient can be quite difficult.

The activity will provide clinicians with the skills and knowledge needed to provide proper patient counselling and education, and enhance adverse-event management in order to achieve seizure control and provide epilepsy patients with an improved quality of life. [See details]

Epilepsy
Steering Committee

Daniel Friedman, MD, MSc
John Hixson, MD

This activity is jointly provided by the Potomac Center for Medical Education and Rockpointe.
This activity is supported by unrestricted educational grants from Eisai and Lundbeck.


AD = Alzheimer's Disease MS = Multiple Sclerosis
PD = Parkinson's Disease EP = Epilepsy

California Neurological Society

Hyatt Centric – Santa Barbara, CA

AD: Friday, May 1, 2015 10:30 AM - 11:30 AM
EP: Fri, Nov 11, 2016 12:15 - 1:15 PM
MS: Sat, Nov 12, 2016 12:15 - 1:15 PM

Hyatt Regency – Newport Beach, CA

AD: Fri, May 13, 2016 12:30 - 1:30 PM

Colorado Society of Clinical Neurologists

Future Meetings TBD

Guard and Grace – Denver, CO

AD: Thurs, March 19, 2015 7:15 PM - 8:15 PM

New York State Neurological Society

Annual 2015 Meeting – Location TBD

AD: Sun, Nov 13, 2016 10:00 - 11:00 AM
MS: Sun, Nov 13, 2016 11:15 AM - 12:15 PM

North Carolina Neurological Society

Location TBD

EP: Fri, February 17, 2017 Time TBD

South Carolina Neurological Association

Future Meetings TBD

The Omni Grove Park Inn – Asheville, NC

MS: Sat, October 8, 2016 2:00 - 3:00 PM
AD: Sat, October 8, 2016 1:00 - 2:00 PM

Pennsylvania Neurological Society

The Sands – Bethlehem, PA

AD Sat, October 22, 2016 8:00 - 9:00 AM
MS: Sat, October 22, 2016 9:00 - 10:00 AM
EP: Sat, October 22, 2016 10:00 - 11:00 AM

Commonwealth Neurological Society (Kentucky)

Future Meetings TBD

Churchill Downs – Louisville, KY

EP: Saturday, May 16, 2015 8:00 AM - 9:00 AM

San Francisco Neurological Society

Monterey Plaza Hotel– Monterey, CA

EP: Fri, March 24, 2017 Time TBD

Fall 2015 Dementia Conference – Sir Francis Drake - San Francisco, CA

AD: Sat, Sept 17, 2016 12:15 - 1:15 PM

Iowa Neurological Association

hotelVetro – Iowa City, IA

EP: Sat, October 8, 2016 8:15 - 9:15 AM

Hawaii Neurological Society

Queen's Conference Center – Honolulu, HI

MS: Sat, October 22, 2016 8:45 - 9:45 AM
AD: Sat, October 22, 2016 10:00 - 11:00 AM